The C-RAD Sentinel system successfully exhibited both by Elekta and the C-RAD US distributor at the annual oncology meeting ASTRO, Chicago.

Press release 2009-11-16
 

C-RAD AB with its three fully owned subsidiaries is all active in the field of
radiation therapy. The company attended and exhibited at the annual oncology
meeting ASTRO in Chicago , USA, 1-4 November. The C-RAD GEMini and Sentinel
systems were presented to clinicians and physists from some of the most
acknowledged centers in radiation therapy. Negotiations and meetings were
accomplished with major vendors in the industry. 

The oncology meeting ASTRO in the US  is annually the largest and most
important event in radiation therapy. This year's meeting was running 1 to 4
November in Chicago, Il. , USA.  the C-RAD Sentinel system was exhibited both
by Acceletronics/Radiation Oncology Systems, the C-RAD distributor in the US
and the radiation therapy company Elekta. The Sentinel system in the Elekta
booth was presented as part of an integrated solution with the treatment couch
called Hexapod Evo. The Elekta booth had a very attractive location at the
entrance of the exhibition. The Hexapod/Sentinel set up was intensely visited.
Important demonstrations to key accounts were made in the Acceletronics booth. 

Erik Hedlund, CEO, C-RAD AB:

"The ASTRO show at the end of the year in the US is the most important oncology
meeting in radiation therapy. Customers are making last decisions to invest but
also plans for the coming year. 

Sentinel has been recognized as a key system for optical scanning. The GEMini
detector with its image quality is getting increasing attention. 

The US market in 2009 has been slow. An important reason has been the
uncertainty about future reimbursement rates for radiation therapy treatments.
New rates have been fixed. In most cases the changes are minor. The market is
expected to return back to normal.” 

 

 

For further information: 

Erik Hedlund, CEO C-RAD AB, Telephone: +46- 18 - 66 69 31, E-Mail:
erik.hedlund@c-rad.se